AorTech International plc
AorTech develops and manufactures medical-grade polyurethanes for use in medical devices and implants. Its products are based on the company's Elast-Eon materials which have various applications including in drug-eluting stents, in orthopedic devices (spinal discs), and for reconstructive/cosmetic uses (breast implants). The company's wholly-owned subsidiary, AorTech Biomaterials, based in Melbourne, Australia, was formed more than a decade ago to commercialize the company's range of medical-grade polyurethanes. Bluehone Investors (chaired by AorTech director Stuart Rollason) holds about 20% of the company's shares.
Contact Details
Office Address
AorTech International plc
Prestige Travel Suite, Barclays Bank House, 81-83 Victoria Road
Surbiton, Surrey, UK KT64NS
Phone: +61-3-9780-1700
Fax: +61-3-9780-1777
Executives
Chairman
Jon P. Pither
CEO and Director
Frank Maguire